Professor of Medicine
Keck School of Medicine at USC
Education
Government High School #1, Abbott Abad, Hazara, N.W.F.P., Pakistan, 1959
F.SC (pre-med) from Islamia College, University of Peshawar, Pakistan, 1962
Khyber Medical College, University of Peshawar, Pakistan, 1967
Internship
House Physician in Internal Medicine, Khyber Teaching Hospital, Peshawar, Pakistan, 9/1/1967–8/31/1968
Job Experience
Pakistan Tobacco Company (British Company), 9/1/1968–1/1/1969
Residencies
House Officer in General Surgery, Orthopedics and Emergency Medicine, hospitals in England 2/1969–1/1970
Senior House Officer, Internal Medicine and Nephrology, Derby City Hospital, England 1/1970–5/1971
MRCP Course and House Job, Whittington and Putney Hospital, London, England 1/1970–5/1970
Senior House Officer in Neurology, Derbyshire Royal Infirmary, England 5/1972–1/1973
Medical Registrar in Internal Medicine, Southend General Hospitals, Essex, England 1/1973–6/1975
Fellowships
Nephrology, The Christ Hospital, Cincinnati, Ohio, 7/1975–7/1977
Advanced Fellowship in Nephrology, LAC+USC Medical Center, 7/1977–7/1978
Licensure
State of California
State of Maryland
British Medical Council
Pakistan Medical Council
Academic Background
Professor of Medicine, University of Southern California, 7/1993–present
Associate Professor of Medicine, University of Southern California, 7/1985–7/1993
Assistant Professor of Medicine, University of Southern California, 7/1981–7/1985
Instructor in Internal Medicine, University of Southern California, 7/1978–7/1981
Attending Physician, LAC+USC Medical Center, 7/1978—present
Attending Physician, Norris Cancer Center, 1985–present
Attending Physician, USC University Hospital, 1990–present
Administrative Positions
Medical Director Emeritus, DaVita/USC Kidney Center, 9/1/2009–present
Director, DaVita/USC Kidney Center, Department of Medicine, University of Southern California, 1/1/1997–9/1/2009
Director, USC Outpatient Dialysis Center, Division of Nephrology, 9/1989–1/1997
Director, Research Laboratories, Division of Nephrology, University of Southern California, 5/1983– 9/1989
Director, Renal Clinics, Division of Nephrology, LAC+USC Medical Center, 7/1985– 9/1987
Teaching Experience
Interns and allied health professionals, Derby City and Derbyshire Royal Infirmary, England, 1/1971–1/1973
Interns and residents, Southend General Hospitals Group, Essex, England, 1/1973–6/1975
Medical students, house staff, and renal fellows, LAC+USC Medical Center, 7/1979–present
Medical students’ ward, instructor/preceptor, LAC+USC Medical Center, 7/1977–1993
Student/resident seminar, LAC+USC Medical Center, 7/1977–present
Attending Physician, medicine, nephrology (ward and consults), LAC+USC Medical Center, 7/1978–present
Mechanism of Diseases (annual), nephrology section for second-year medical students, University of Southern California, 1981–present
Internal Medicine Review Course, four different years since 1981
Morning Report for Medical Residents, since July 1998
Committee Memberships
USC University Hospital, Los Angeles, CA
• Member, Ethics Committee
• Member, Pharmacy and Therapeutic Committee
LAC+USC Medical Center, Los Angeles, CA
• Chairman, Internal Review Committee, Division of Dermatology, December 1999
• Utilization Committee, 7/1987–7/1994
• Advisory Committee for Private Practice, Department of Medicine, 7/1985–77/1987
• Professional Services Committee, Department of Medicine, 7/1987–7/1997
• Quality Improvement Committee, Department of Medicine, 7/1993–present
• Operation and Services Subcommittee, Private Practice and Growth, Department of Medicine, 7/1997–2002, 7/01/08–present
• Member, IRB, July 1996–present
Member
National Kidney Foundation
National Kidney Foundation of Southern California
American Heart (Renal Section)
Society for Advancement of Science
Association of Pakistani Physicians of North America
American Society of Nephrology
International Society of Nephrology
Awards
National Kidney Foundation of Southern California
• Meritorious Services as a Board Member, 1993
• Outstanding Effort for Annual Tribute Dinner, 1994
• Volunteer Services Award, 1996
• Leadership Award, Chairman of Board (1997–1999), 06/24/1999
• Volunteer Award (Notable Achievement & Excellence) at the Kidney Run/Walk, Lake Sherwood, Westlake Village, CA, 2000
• Spirit of Nephrology Award (annual award given to outstanding nephrologists), 6/8/2000
Association of Pakistani Physicians of North America
• Service Award, Los Angeles, CA, 1998
• Dedicated Member Award (Organizing Committee), 19th APPNA Winter Conference, Peshawar, Pakistan, 1998
• Service to Community in Medicine Award (Western Chapter), 2007
Keck School of Medicine, USC
• Fellows Appreciation Award, Renal Fellows, Division of Nephrology, 1999
• Outstanding Teacher, Year II Medical Students, Class of 2000
• II-Year Medical Students Appreciation Certificate (Introduction to Clinical Medicine), 2001, 2002, 2003
• Certificate of Recognition (Introduction to Clinical Medicine), Department of Family Medicine, 2004–2005
• Medical Student Appreciation Certificate, 2007
DaVita/USC Kidney Center
• DaVita Core Values Excellence Award, 12/2005
• Certificate of Participation, NIDDK Frequent Hemodialysis Network (FHN) Trial, 2006–2009
• Certificate of Excellence, DaVita, Inc. (Wild West Division), 12/2007
• Dr. Pepper Award, DaVita, Inc. (Wild West Division), 2/3/2008
National Philanthropy Award, Los Angeles, CA, 1996
Certificate of Recognition and Appreciation for official participation in DOPPS study, 1996–2000
Speaker Award, International Scientific Conference, Rawalpindi Medical College, Peshawar, Pakistan, 1998
Falcon Award, Outstanding Contributions to Pakistani-American Community, Los Angeles, CA, 03/23/1999
Honors
The Global Directory of Who’s Who
• Lifetime member as of 2007
• Professional of the Year, 2007
• Professional of the Year, Nephrology, 2009
• Top Doctor, 2009
• V.I.P. Member, 2011
• Top Professional, 2011
• Top Doctor, 2012
• Professional of the Year in Nephrology, 2012
Consumer Research Council of America
• America’s Top Physicians, 2008
• America’s Top Physicians, Nephrology, 2010
American Biographical Institute
• Man of the Year in Medicine and Healthcare, 2008
• Man of the Year Award, American Biographical Institute, 2010
National Kidney Foundation of Southern California
• Member, Nominating Committee, 1987–1989
• Board Member, 1989–1993, 1994–2005
• Member, Research Committee, 1990, 1991
• Committee Member, Annual Tribute Dinner, 1992, 1997
• President-Elect, Medical Advisory Board, 7/1992–7/1994
• Delegate Trustee, 1994–2001
• Chairman, Annual Tribute Dinner, 1994, 1995
• President, Medical Advisory Board, 7/1994–7/1996
• Chairman, Budget Committee, Medical Advisory Board, 7/1994–7/1996
• Chairman, Nominating Committee, Medical Advisory Board, 7/1994–1998
• Vice Chairman, Symposium Planning Committee, 27th Annual Scientific Symposium of Kidney Diseases, 1996
• Co-Chairman, Host Committee, Clinical Nephrology Spring Meetings, 1996
• Chairman, Symposium Planning Committee, 28th Annual Scientific Symposium of Kidney Diseases, 1997
• Interim Chairman, Board of Directors, 1/1/1997–7/1/1997
• Chairman, Board of Directors, 7/1/1997–7/1/1999
• Immediate Past Chairman, Board of Directors, 7/1/1999–7/1/2001
• Chairman, Patient’s Services Committee, 7/1/1999 –2001
Association of Pakistani Physicians of North America (APPNA)
• Secretary, Khyber Alumni Association, 1987–1989
• Member, Host Committee, 19th Summer Scientific Committee, Los Angeles, CA, 1998
• Member, Organizing Committee; Chairman, Scientific Committee, 19th Winter International Scientific Conference, Khyber Medical College, Peshawar, Pakistan, 1998
• Vice President, Khyber Alumni Association, 6/1999–6/2000
Southern California Renal Disease Council, Inc., ESRD Network 18
• Board Member, 1997–2005
• President-Elect, Board of Directors, 1998–2000
• President, Board of Directors, 1/2000–1/2002
• Immediate Past President, Board of Directors, 1/2002–1/2004
President, Doctors Affairs, Derby City Hospital, England, 1971–1973
Secretary for Doctors Affairs, Southend General Hospitals Group, 1973–1975
Member, Compliance Committee, MDRD, NIH Study, 1989–1993
Member, Fellowship Study Section, American Heart Association, 1989–1991
Member, Fellowship Study Section, National Kidney Foundation, 1989–1991
Member, MFA Task Force on evaluation of administrators, University of Southern California, 1990
Board Member, Poison Center, LAC+USC Medical Center, Los Angeles, CA, 1996–1997
Medical Faculty Assembly Representative, Department of Medicine, 7/1/1996–7/1/1998
Board Member, Southern California Renal Disease Council, 1997–2005
Certificate of Membership, American Diabetes Association, 2004
Strathmore, Who’s Who, 2006–2007; life membership, 2007
America’s Registry of Outstanding Professionals, 2007–2008; lifetime member as of 2008
Super Doctor (Southern California), Key Professional Media, Inc., 2008
America’s Registry of Outstanding Professionals, Lifetime Featured Member, 2009
Lifetime Achievement Award, International Biographical Centre, Cambridge, England, 2010
Fellow of the American Society of Commerce, 2011
Outstanding Physician in Hypertension Diagnosis and Management Award, National Institute of Hypertension, 2011
Member (Nephrology Section), American Honor Society, 2011
Top Nephrologist, The Leading Physicians of the World, 2012
Research Funding, Co-Investigator
Parathyroid hormone and uremia, $619,216, 7/10/1981–6/30/1986
Parathyroid hormone and uremia, $632,707, 7/1/1986–6/30/1991
Thyroid hormone kinetics in kidney disease, $318,518, 12/1/1984–11/30/1988
Modification of diet in renal disease, $1,826,978, 1988–1993
Parathyroid and uremia, NIH, $818,775
Coronary artery calcification, NIH, $367,419, 7/1/2001–6/30/2006
Clinical Trials
Modification of diet in renal disease (co-investigator), 1988–1993
Use of BioLogic-DT system in treatment of drug overdose (principal investigator), 1991–1994
Multicenter trial to compare efficacy of 125, Vitamin D3 plus 24, 24 Vitamin D in the treatment of osteitis fibrosa cystica maintained on chronic hemodialysis (co-investigator), 1990–1993
Multicenter trial, Morbidity and Mortality of Hemodialysis (MMHD), Dialysis Outcome Practice Pattern Study (DOPPS), 1996–2000
IMS EPO tracking stud, multicenter trial, 1996
Open-label study of the effects of Zemplar on patients with high bone turnover renal osteodystrophy (principal investigator), Abbott Pharmaceuticals ($75,000), 10/2001
Correction of hemoglobin and outcomes in renal insufficiency (principal investigator), Ortho Biotech/Care Stat ($112,500 for three years)
A Phase 111b, multicenter, two-cohort, randomized study, with an open-label run-in and a long-term extension phase (principal investigator), Shire, continuing
FNH (daily hemodialysis) (co-investigator), NIH
Treat study (principal investigator), Amgen, continuing
ASCEND, Speedel ($7,087.40) (study terminated by sponsors, 2006)
EPO-AKD-3001, Johnson and Johnson ($10,835.50)
Roche Bioscience ($5,282.50)
Amgen, Inc. ($80,586.18)
Extension study for hyperphosphatemia (principal investigator), Shire ($9,679.11)
Novo Nordisk study (principal investigator)
Affymax study (principal investigator) ($139,397.57)
National and International Scientific Conferences, Invited Speaker
National Kidney Foundation
• Renal biopsy workshop: The surprises for renal biopsy. 18th Annual Scientific Meeting, Washington, DC, 1988
National Kidney Foundation of Southern California
• Calcium, Vitamin D and Parathyroid Hormone. 22nd Annual Scientific Symposium on Kidney Disease, Los Angeles, CA, 1982
• Glucose metabolism in chronic renal failure. 25th Annual Scientific Symposium on Kidney Disease, 1985
• Dyslipidemia of ESRD. 36th Annual Scientific Symposium, Long Beach, CA 1996
Association of Pakistani Physicians of North America (APPNA)
• Diabetic nephropathy. 6th International Conference on Health and APPNA Annual Convention, Karachi, Pakistan, 1985
• Diabetic nephropathy and its management. 14th Annual Winter Conference, 1993
• CKD, DM, and HTN. Annual Convention, Irvine, CA, 2007
International Conferences on Health, Peshawar, Pakistan
• Spectrum of acute renal failure, 1985
• Renal disease in subacute bacterial endocarditis, 1986
• Medical management of nephrolithiasis, 1986
• Renal metabolic complications of antihypertensive agents, 1987
Bari International Seminars in Nephrology, Bari, Italy
• Rhabdomyolysis. 2nd International Seminar, 1985
• Renal disease associated with mixed connective tissue disease. 3rd International Seminars, 1987
New Actions of Parathyroid Hormone (international conference)
• PTH and carbohydrate intolerance in uremia. Kobe, Japan, 1987
• PTH, brain, calcium and EEG. Kobe, Japan, 1987
• Excess PTH and right ventricular function. Kyoto, Japan, 1994
Hospital Presentations
• Pre-end stage renal disease. Kidney Month Lecture, general family practice, St. Vincent Medical Center, Los Angeles, CA, March 21, 2002
• Hypertension in CKD. West Hills Hospital, CA, 2006
• Drug toxicity in dialysis patients. Mission Community Hospital, San Fernando Valley, CA, 2009
• Chronic kidney disease. Verdugo Hospital, Glendale, CA, 2009
• Acute renal failure. Bellflower Medical Center, Bellflower, CA, 2009
• Chronic kidney disease. Promise Hospital, Paramount, CA, 2009
Visiting Professor, Nassau County Medical Center, East Meadow, NY, 1990
Visiting Professor, Khyber Medical College, Peshawar, Pakistan, July 15–July 30, 1991
125 (OH)2 D and hypercalcemia in diuretic phase of acute renal failure due to rhabdomyolysis. 6th Vitamin D Workshop, Merano, Italy, 1985
Electrolyte disturbances in rhabdomyolysis. Advances in Non-Invasive Nephrology International Conference, Vienna, Austria, 1986
The adverse effects of excess PTH on lipid metabolism in chronic renal failure (CRF) (pathophysiology of patients treated for 15–20 years). 6th International Capri Conference on Uremia, Capri, Italy, 1989
The adverse effects of excess PTH on lipid metabolism in CRF. International Symposium on Calcium Regulating Hormone, Body Fluids, and Kidney, Nara, Japan, 1990
Renal calculi, renal disease, causes, effect and management. Sponsored by CIGNA, Los Angeles Hilton, Los Angeles, CA, 1991
Hyperparathyroidism and hyperlipidemia in CRF. Conference Leo Ambard, Strasbourg, France, 1991
Diabetic nephropathy and management (sponsored by Indian Society of Medicine of North America). Los Angeles, CA
HIV and hemodialysis. Clinical Symposium (sponsored by Clinishare), Los Angeles, CA, 1992
Vascular access: problem and treatment. 34th Annual Symposium on Kidney Disease, La Jolla, CA, 1994
Left ventricular hypertrophy. ANNA, Anaheim, CA, 1996
Pregnancy and hypertension. International Scientific Conference, King Edward Medical College, Lahore, Pakistan, 1998
Pregnancy and renal failure. Preeclampsia, pregnancy and hypertension. International Scientific Conference, Rawalpindi Medical College, Pakistan, 1998
Hemodialysis in diabetic patients. Second International Conference on Uremic Research, Nara, Japan, April 2001
Tissue calcification. Dominick Gentile, M.D. annual keynote address, 2001
Meeting & education conference, Palm Springs, CA, September, 14, 2001
Cardiovascular epidemic in chronic kidney disease: calcification of arteries. 5th Annual Nephrology Symposium, Kaiser Permanente Continuing Medical Education, Long Beach, CA, May 3–4, 2002
New challenges and strategies: chronic kidney disease. International Symposium at Khyber Medical College, Peshawar, Pakistan, December 2004
Chairperson, Scientific Sessions
National Kidney Foundation of Southern California
• 25th Annual Scientific Symposium on Kidney Disease. Palm Springs, CA, 1985
• 27th Annual Scientific Symposium on Kidney Disease, La Jolla, CA, 1987
• 28th Annual Scientific Symposium on Kidney Disease, Ventura, CA, 1988
• 30th Annual Scientific Symposium on Kidney Disease, Palm Springs, CA, 1990
• A Creative Team Approach to Optimize Outcomes with Renal Failure; Hands-On and Procedural Training Workshop: Renal Ultrasonography and Percutaneous Renal Biopsy; Meet the Professor: “Drug Induced Renal Function,” 5th Annual Spring Clinical Nephrology Meeting, Anaheim, CA, 1996
International Conference on Health. Peshawar, Pakistan, 1985
9th International Congress of Nephrology. Los Angeles, CA, 1985
Advances in Non-Invasive Nephrology (international conference), Vienna, Austria, 1985
American Society of Nephrology. San Antonio, TX, 1988
Symposium Moderator: Diabetes and its Sequele. 14th Annual Winter Conference of Association of Pakistani Physicians of North America (APPNA). Peshawar, Pakistan, 1993
Nutrition: The Neglected Aspects of Medical Treatment. Peshawar, Pakistan, 1993
3rd International Conference on New Actions of Parathyroid Hormone. Kyoto, Japan, 1994
Hyperphosphatemia, Tissue Calcification and PTH in ESRD. Cedars-Sinai Medical Center, Los Angeles, CA, October 12, 1999
Anemia in Dialysis Patients. San Diego, CA, 2000
The Effect of Zemplar on Excess PTH. Community lecture, Los Angeles, CA, 2000
PTH-Associated Complications in CRF. Community lecture, Los Angeles, CA, 2000
Mini-Symposium on Kidney Diseases. Khyber Medical College, Peshawar, Pakistan.
Reviewer
Mineral and Metabolism, since 1982
American Journal of Nephrology, since 1981
Kidney International, since 1987
American Journal of Kidney Disease, since 1988
Abstract reviewer, American Society of Nephrology
Advisory Consultant
Total Renal Care, Physician Advisory Board Meeting, Las Vegas, Nevada, 1997, 1998, 1999
DCA Research Foundation, Physician Advisory Meeting, Symposium on “Integrating Informatics and Telemedicine to Improve Clinical Outcomes,” Las Vegas, Nevada, February 4–7, 1999
Ferrilecit Consultant Meeting, Marina del Rey, CA, July 22, 2000
Genzyme, Renagel Capsules, consultant feedback meeting, Washington, DC
Baxter, New Orleans, LA
Renal Advisory Meeting, Abbott Renal Care, Vail, CO, January 23–24, 2000
Baxter, Care Advocacy Development and Speaker Training Meeting, Aventura, Florida, October 28–29, 2000
Publications
Akmal, M. and Manzler, A.D.: Simplified assessment of pituitary-adrenal axis in a stable group of hemodialysis patients. Trans. Am. Soc. of Intern. and Org. XXXIII: 703–707, 1977.
Akmal, M.; Goldstein, D.A.; Telfer, N.; Wilkinson, E. and Massry, S.G.: Resolution of muscle calcification in rhabdomyolysis and acute renal failure. Ann. Int. Med. 89: 928–930, 1978.
Massry, S.G.; Goldstein, D.A. and Akmal, M.: Parathyroid hormone and the uremic syndrome. Contro. Nephrol. Vol. 1, 1978.
Feinstein, E.I.; Akmal, M.; Goldstein, D.A.; Telfer, N. and Massry, S.G.: Hypercalcemia and acute widespread calcification during the oliguria phase of acute renal; failure due to rhabdomyolysis. Min. Elect. Metab. 89:928–930, 1979.
Haldimann, B.; Goldstein, D.A.; Akmal, M.; and Massry, S.G.: Renal function and blood levels of divalent ions in acute pancreatitis. A prospective study in 99 patients. Min. Elect. Metab. 3:190–199, 1980.
Feinstein, E.I.; Akmal, M.; Telfer, N. and Massry, S.G.: Delayed hypercalcemia in patients with acute renal failure associated with non-traumatic rhabdomyolyis. Arch. Int. Med. 141:753–755, 1981.
Akmal, M.; Valdin, J.; McCarron, M.D. and Massry, S.G.: Rhabdomyolysis with and without acute renal failure in patients with phencyclidine intoxication. Am. J. Nephrol. 1:91–96, 1981.
Akmal, M.: Clinical aspects of renal disease associated with mixed connective tissue disease, in Glassock, Goldstein. Recurrent acute renal in a patient with mixed connective tissue disease. Am. J. Nephrol. 2:282–290, 1982.
Glassock, R.J.; Goldstein, D.A.; Akmal, M.; Boswell, W.D. and Eknoyan, G.: Hematuria in a 42 year old woman. Am. J. Nephrol. 2:233–244, 1982.
Glassock, RJ, Goldstein, DA, Akmal, M, Kitridou, R and Koss, M.: Recurrent acute renal failure in a patient with mixed connective tissue disease. 2(5)287–290, 1982.
Massry, S.G.; Frohling, P.T. and Akmal, M.: Is parathyroid hormone involved in progression of renal failure (Prevention of Progressive Uremia). Vol. 1:125–127, 1982.
Malluche, H.H.; Akmal, M.; Meir, E.; Norman, A. and Massry, S.G.: Parathyroid hormone reverses effects of 125 (OH)2 vitamin D on bone dynamics. Vitamin D, chemical, biochemical and clinical endocrinology of calcium metabolism proceedings of the fifth workshop on vitamin D, Williamsburg, VA, USA, Editors: A. W. Norman, K. Schaeffer, D.V. Herrath, and H.G. Grigoleit. 539–544, 1982.1.
Akmal, M. and Massry, S.G.: Nerve damage associated with rhabdomyolysis. Arch. Intern. Med. 143:835–837, 1983.
Massry, S.G. and Akmal, M.: Metabolic and endocrine abnormalities after renal transplantation. Textbook of Nephrology, Eds. Shaul G. Massy and Richard J. Glassock. 1st Edition, Chapter 74, Part 3, pp.9.34–9.36, 1983.
Akmal, M.; Kidridou, R.; and Massry, S.G.: Mixed connective tissue disease. Textbook of Nephrology, eds. Shaul G. Massry and Richard J. Glassock. 1st Edition, Chapter 42, Part2, pp. 6.94–6.96, 1983.
Massry, S.G.; and Akmal, M.: Heroin associated nephropathy. Textbook of Nephrology, eds. Shaul G. Massry and Richard J. Glassock. 1st Edition, Chapter 43, Part 4, pp. 6.202–6.204.
Blau, R.H.; Akmal, M.; Koss, M. and Quismorio, F.: Palpable leg purpura and renal failure in a 23 year old man. Western J. Med. 140:60–65, 1984.
Akmal, M.; Goldstein, D.A.; Multani, S. and Massry, S.G.: Role of uremia, brain CA and parathyroid hormone on changes in electroencephalogram in chronic renal failure. Am. J. Physiol. 245:F575–F579, 1984.
Akmal, M.; Tuma, S.; Goldstein, D.A.; Pattabhiraman, R.; Bernstein, L. and Massry, S.G.: Intact and carboxyterminal PTH do not cross the blood-cerebrospinal fluid barrier. Proceedings for Experimental Biology and Medicine 1976:434¬437, 1984.
Akmal, M.; Massry, S.G.; Goldstein, D.; Fanti, P.; Weisz, A. and DeFranzo, R.A.: Role of parathyroid hormone in the glucose intolerance in uremia. J. Clin. Invest. 75:1037–1044, 1985.
Akmal, M.; Telfer, N.; Ansari, A. and Massry, S.G.: Erythrocyte survival in chronic renal failure: Role of secondary hyperparathyroidism. J. Clin. Invest. 76:1695–1698, 1985.
Akmal, M.: Electrolytes disturbances in patients with rhabdomyolysis. Advances in Non-Invasive Nephrology, by Gert Lubec and Vito Campese, pp. 120– 122, 1985.
Akmal, M.; Kaptein, E.M.; Bertram, J. and Massry, S.G.: Acute renal failure due to bilateral urethral obstruction by metastases from breast cancer. Nephron. 42:23–28, 1986.
Akmal, M.; Bishop, J.E.; Telfer, N.; Norman, A.W. and Massry, S.G.: Hypocalcemia and hypercalcemia in patients with rhabdomyolysis with and without acute renal failure. J. Clin. Endocrinol Metab. 63:137–142, 1986.
Kitridou, R.C.; Akmal, M.; Turkel, S.; Ehresmann, S.G.; Quismorio, F.P. and Massry, S.G.: Renal involvement in mixed connective tissue disease. A longitudinal clinico-pathological study. Seminars Arth. Rheumat. 16:135–145, 1986.
Massry, S.G. and Akmal, M.: Osmotic fragility of red blood cells, secondary hyperparathyroidism, and uremia. Nephron. 43:70–71, 1986.
Akmal, M.: In Feinstein, Nephrotic syndrome in a woman with diabetes mellitus and rheumatoid arthritis. Am. J. Nephrol. 7:77–83, 1987.
Akmal, M; Goldstein, D.A.; Kletzky, O.A. and Massry, S.G.: Hyperparathyroidism and hypotestosteronemia of acute renal failure. Am. J. Nephrol. 8:166–169, 1988.
Fadda, G.Z.; Akmal, M.; Primdas, F.H.; Lipson, S.G. and Massry, S.G.: Insulin release from pancreatic islets: Effects of CRF and excess PTH. Kid. Int. 33:1066–1072, 1988.
Soliman, A.R.; Akmal, M. and Massry, S.G.: Parathyroid hormone interferes with extrarenal disposition of potassium in chronic renal failure. Nephron. 52:262–267, 1989.
Fadda, S.Z.; Akmal, M.; Soliman, A. and Massry, S.G.: Correction of glucose intolerance and the impaired insulin release of chronic renal failure by verapamil. Kid. Int. 36:773–779, 1989.
Massry, S.G.; and Akmal, M.: Lipid abnormalities, renal failure and parathyroid hormone. Am. J. Med. 87:5–42N, 1989.
Kaptein, E.M.; Hoopes, M.T.; Pattabhiraman, R; Akmal, M. and Massry, S.G.: Separation of iodothyronines from iodinated metabolites in serum from reverse T3 tracer kinetic studies in man and dog: A comparison of two metals. Horm. Metabol. Res. 21:678–681, 1989.
Akmal, M.: Rhabdomyolysis associated acute renal failure. IM Internal Medicine for the Specialist IM/10:118–124, 1989.
Massry, S.G.; Fadda, G.Z.; Akmal, M.: Carbohydrate intolerance and impaired pancreatic insulin release in chronic renal failure: Role of excess blood levels of parathyroid hormones. pp. 219–245, 1989. In: New Actions of Parathyroid Hormone. Edited by Shaul G. Massry and Takuo Fujita.
Akmal, M. and Massry, S.G: Metabolic and endocrine abnormalities after renal transplantation. Textbook of Nephrology, eds. Shaul G. Massry and Richard J. Glassock. 2nd Edition, 1989.
Akmal, M. and Shaul G. Massry.: Mixed connective tissue disease. Textbook of Nephrology, eds. Shaul G. Massry and Richard J. Glassock, 2nd. Edition, pp. 703–705, 1989.
Massry, S.G. and Akmal, M.: Heroin associated nephropathy. Textbook of Nephrology, eds. Shaul G. Massry and Richard J. Glassock, 2nd. Edition, pp. 848–851, 1989.
Akmal, M.: Renal disease associated with mixed connective tissue. Advances in Experimental Medicine and Biology 252:53–58, 1989.
Akmal, M.; Kasim, S.E.; Soliman, A.R.; Massry, S.G.: Excess parathyroid hormone adversely affects lipid metabolism in chronic renal failure. Kid. Int. 37:854–858, 1990.
Akmal, M.; and Massry, S.G.; Reversible hepatic dysfunction associated with rhabdomyolysis. Am. J. Nephrol. 10:49–52, 1990.
Kaptein, E.M.; Hoopes, M.R.; Ferguson, D.C.; Satyadi, E.C.; Akmal, M.: Comparison of reverse triiodothyronine distribution and metabolism in normal dogs and humans. Endocrinology 126: 2003–2014, 1990.
Fadda, G.; Akmal, M.; Lipson, L. and Massry, S.G.: Direct effect of excess PTH on insulin secretion from pancreatic islets. Am. J. Physiol. 258: (Endocrinol-Metab. 21:E975-E984, 1990).
Akmal, M. and Massry, S.G.: Decreased motor nerves conduction, chronic renal failure and excess PTH. Proceedings for Experimental Biology and Medicine 195:202–207, 1990.
Akmal, M.: and Om P. Sharma: Renal sarcoidosis; A reminder (Editorial). Chest 97:1284–1285, 1990.
El-Shahawy, M.A.; Gadallah, M.F.; Teitelbaum, G.P.; Kaptein, E. and Akmal, M.,: Compression of the left brachiocephalic vein by the innominate artery resulting in massive arm edema in a hemodialysis patient. Am. J. Nephrol. 12:108–110, 1992.
Akmal, M.: Rhabdomyolysis in a patient with hypocalcemia due to hypoparathyroidism. Am. J. Nephrol. 13:61–63, 1993.
Akmal, M.; Perkins, S., Kasim, S.; Oh, H., Smogorzewski, M., Massry, S.G: Verapamil prevents CRF-induced abnormalities in lipid metabolism. Am. J. Kidney Dis. 22(1):158-163, 1993.
Macho, R; Ameriso, S.; Akmal, M.: Mohler, J.; Massry, S.G.; Meiselman, H.; Fisher, M.: Hemorrheological factors, oxygenation and age correlates of middle cerebral artery velocity. Stroke 24:1025–1028, 1993.
El-Shahawy, M.; Francis, R.; Akmal, M. and Massry, S.G.: Recombinant human erythropoietin shortens bleeding time (BT) and corrects abnormal platelets aggregation (PA) in hemodialysis patients (HDP). Clinical Nephrology 41(5): 308–313, 1994.
Akmal, M.; Sawelson, S.; Karubian, F. and Gadallah, M.: The prevalence of occult blood loss in patients with predialysis advanced chronic renal failure (CRF), or receiving dialytic therapy. Clinical Nephrology 42:198–202, 1994.
Liou, H.H.; Shooh-Shan, C.; Shi-Ching, T.; Ching, Chun, C.; Shih-Chun, W.; Tung-Po, H.; Akmal, M.: Intravenous or oral calcitriol treatment in chronic hemodialysis patients with secondary hyperparathyroidism: Comparative study. Min. Elec. Metab. 20:97–102, 1994.
Akmal, M.; Massry, S.G.: Renal complications associated with heroin. In: Textbook of Nephrology, 3rd Edition, eds, S.G. Massry, R.. Glassock (Williams and Wilkins CO). 3rd. Edition, Part 6, pp. 970–974, 1994.
Akmal, M.; Barndt, R., Ansari, A. and Massry, S.G.: Right ventricular hypertrophy (RVH) and pressure (RVP) mean pulmonary artery pressure (MPA) and lung calcification in CRF. Kidney Intern. 47:158–163, 1995.
Alexiewicz, J. M; Smogorzewski, M; Klin, M; Akmal, M; Massry, S.G.: Effect of treatment of hemodialysis patients (HD) with nifedipine on metabolism and function of polymorphonuclear leucocytes (PMNL). Am J Kidney Dis. 25(3): 440–444, 1995.
Akmal, M.; Bughi, S.; and Kaptein, E.M.: Endocrine dysfunction in chronic renal failure. In: Clinical Dialysis, 3rd.Edition, Nissenson A, Fine RN, and Gentile D, Appleton and Lange, pp. 714–743, 1995.
Alexiewicz, J. M; Smogorzewski, M; Akmal, M; Klin, M; Massry, S.G: Nifedipine reverses the abnormalities in [CA2]i and proliferation of B-cells from dialysis patients. Kidney Intern. 50:1249–1254, 1996.
Alexiewicz, M.; Smogorzewski, M.; Gill, S.K.; Akmal, M.; Massry, S.G.: Time course of the effect of nifedipine therapy and its discontinuation on [CA2+]i and phagocytosis of polymorphonuclear leukocytes from hemodialysis patients. Am. J. Nephrol. 17:12–16, 1997.
Alexiewicz, M; Smogorzewski, M; Akmal, M; Massry, S.G: A longitudinal-study on the effect of nifedipine therapy and its discontinuation on [CA2]i and proliferation of B-Lymphocytes of dialysis patients. Am J Kidney Dis. 29(2):233–238, 1997.
Akmal, M..: Disfuncion endocrina en la insuficiencia renal conica y alteraciones de los carbohidratos y lipidos. Capitulo 21: pp 559–637, 1997. Insuficiencia Renal Cronica, Dialysis y Transplante Renal by Llach and Valderrabano (2nd Edition).
Ziouzenkova, O; Asatryan, L; Akmal, M; Tetta, C; Wratten, M.L; Loseto-Wich, G; and Sevanian, A: Oxidative cross-linking of Apo B100 and hemoglobin results in low density lipoprotein modification in blood: Relevance to atherogenesis caused by hemodialysis. J Biol Chem. 2; 274(27): 18916–24.
Kaptein, EM; Levenson, H; Siegel, ME; Gadallah, M; Akmal, M: Radioiodine dosimetry in patients with end-stage renal disease continuous ambulatory peritoneal dialysis therapy.
Akmal, M, S.G. Massry: Heroin associated nephropathy. Textbook of Nephrology, eds. Shaul G Massry and Richard J. Glassock. 3rd Edition (2001).
Akmal, M: Hemodialysis in diabetic patients. AJKD 33(4) Suppl 1, S195– S199, 2001
Ash, SR; Levy, H; Akmal, M; Mankus, RA; Sutton, JM; Emery, DR; Scanl, JC; Blake, DE; Carr, DJ: Treatment of severe tricyclic antidepressant overdose with extracorporeal sorbent detoxification. Adv. Ren. Replace. Ther. 9(1): 31–41, 2002.
Manuscripts in Preparation
Akmal, M65. Akmal, M.; Koss, M. et al.: The spectrum of postpartum renal disease.
Akmal, M.; et al.: Histologic diabetic renal lesions in the absence of chemical diabetes.
Akmal, M and Sharma, O.: Bone tuberculosis in a patient on steroid therapy for sarcoidosis.
Akmal, M. et al.: Cardio-pulmonary calcification in chronic renal failure.
Rhabdomyolysis: Long-term experience.
Silent diabetic nephropathy.
Pregnancy in dialysis patients.
Tissue calcification in CKD: The effect of excess PTH.
Increase in CPK isoenzymes in dialysis patients.
Kidney disease in leprosy.
Abstracts
Akmal, M. and Manzler, A.D.; Simplified assessment of pituitary-adrenal axis in a stable group of chronic hemodialysis patients. A.S.A.I.O. XXXIII. Presented in Montreal, 1977.
Akmal, M.; Goldstein, D.; Telfer, N.; Wilkinson, E. and Massry, S.G.: Muscle clarifications in acute renal failure due to rhabdomyolysis and their resolution after recovery of renal function. Kid. Int. 14–644, 1978. Presented at 11th. Annual Meeting of American Society of Nephrology, in New Orleans, Louisiana, 1978.
Kitridou, R.C.; Akmal, M.; Ehresman, G.R.; Quismorio, F.P. and Massry, S.G.: Nephropathy in mixed connective tissue disease. Arthr. Rheum. 22: 704, 1980. Presented at the American Rheumatism Association in 1980.
Akmal, M.; Goldstein, D.A.; Multani, S. and Massry, S.G.: Parathyroid hormone and glucose intolerance in uremia. Kid. Int. 19:194, 1981. Presented at the 13th Annual Meeting of American Society of Nephrology in 1980, in Washington, DC
Melluche, H.H.; Akmal, M.; Goldstein, D.A. and Massry, S.G.: Role of parathyroid hormone in renal osteodystrophy. Presented at the 8th. International Congress of Nephrology, Athens, Greece in 1981.
Melluche, H.H.; Akmal, M.; Goldstein, D.A.; Meir, E.; Norman, A.W. and Massry, S.G.: The role of lack of hormone (PTH) in the pathogenesis of uremic low turnover osteodystrophy. Kid. Int. Vol. 21, No. 1, 1982. Presented at 14th. Annual meeting of the American Society of Nephrology, in 1981, in Washington, DC
Akmal, M.; Telfer, N. and Massry, S.G.: Hypocalcemia and calcium deposition in soft tissues with acute renal failure without rhabdomyolysis and in those with rhabdomyolysis with and without acute renal failure. Kid. Int. Vol. 21, No. 1, 1982. Presented at the 14th Annual Meeting of the American Society of Nephrology, in 1981, in Washington, DC
Melluche, H.H.; Akmal, M.; Meir, E.; Norman, A.W. and Massry, S.G.: Parathyroid hormone is needed for the positive effect of 1, 25 (OH) 2 vitamin D on bone formation and mineralization. Bone and Mineral Research, 1982. Presented at the American Society for Bone and Mineral Research, in 1982, at San Francisco, CA.
Telfer, N.; Akmal, M. and Massry, S.G.: Technetium 99-methyl diphosphonate (DMP) soft tissue uptake in acute renal failure (ARF) with and without rhabdomyolysis (RBD) and in RBD without renal failure. J. Nuclear Med. Vol. 23, No. 5, 1982. Presented at the Annual Meeting of American Society of Nuclear Medicine, in 1982, at Miami Beach, FL.
Malluche, H.H.; Akmal, M.; Meir, E.; Norman, A.W. and Massry, S.G.: 125 (OH) vitamin D increases bone formation and mineralization in uremic dogs. An effect dependent upon presence of parathyroid hormone. AFC Midwest 1982.
Akmal, M.; Goldstein, D.A.; Multani, S. and Massry, S.G.: Role of uremia, increased brain calcium (Ca) and parathyroid hormone on changes in electroencephalogram (EEG) in chronic renal failure. Kid.Int. Vol. 23, No. 1, 210, 1983. Presented at the 15th Annual Meeting of the American Society of Nephrology in 1982, at Chicago, IL.
Akmal, M.; Goldstein, D.A.; Tuma, S.; Fanti, P.; Pattabhiraman, R. and Massry, S.G.: The effect of PTH on blood brain barrier. Clin. Research Vol. 31, No. 1, 52A.
Akmal, M.; Massry, S.G. and DeFronzo, R.: Role of parathyroid hormone in insulin secretion and glucose metabolism in chronic renal failure. Kid. Int. Vol. 25:24, 1984. Presented at the 16th Annual Meeting of the American Society of Nephrology in 1983, Washington, DC.
Akmal, M.; Norman, A.W.; Bishop, J. and Massry, S.G.: 125 (OH)2 D3 and hypercalcemia in diuretic phase of acute renal failure due to rhabdomyolysis. Page 443, Sixth Vitamin D Workshop, Merano, Italy, 1985. Presented at Merano, Italy, in 1985.
Akmal, M.; Norman, A.W.; Bishop, J. and Massry, S.G.: 125 (OH) 2 D and hypercalcemia in diuretic phase of acute renal failure due to rhabdomyolysis. Kid. Int. 27:226, 1985.
Fadda, G.Z.; Akmal, M.; Primdas, F.; Lipson, L. and Massry, S.G.: Direct evidence for an inhibitory effect of parathyroid hormone (PTH) on insulin release in chronic renal failure (CRF). Kid. Int. 31:384, 1987. Presented at the 19th.Annual Meeting of the American Society of Nephrology, in 1986, in Washington, DC
Ansari, A.N.; Hung, G.L; Siegel, M.E.; Lundell, C. and Akmal, M.: The detection of renal artery stenosis with captopril renography in patients on antihypertensive therapy. Nuclear Medicine, 1987. Presented at the Annual Meeting of American Society of Nuclear Medicine.
Fadda, G.Z.; Akmal, M.; Lipson, L. and Massry, S.G.: Evidence for correction of glucose intolerance and insulin secretion by verapamil in chronic renal failure. Presented at the American College of Physicians Meeting in 1988, at San Diego, CA.
Fadda, G.Z.; Akmal, M.; Soliman, A.R.; Lipson, L.G. and Massry, S.G.: Correction of glucose intolerance (GINT) and the impaired insulin release of chronic renal failure (CRF) by verapamil. Kid. Int. 35:427, 1989. Presented at the 21st. Annual Meeting of the American Society of Nephrology, in 1988, at San Antonio, Texas.
Akmal, M.; Kasim, S.E.; Soliman, A.R. and Massry, S.G.: Excess parathyroid hormone adversely affects lipid metabolism in chronic renal failure (CRF). Kid. Int. 35:422, 1989. Presented at the 21st. Annual Meeting of the American Society of Nephrology, in 1988, at San Antonio, TX.
Akmal, M.; Kasim, S.E.; Soliman, A.R. and Massry, S.G.: The adverse effects of excess parathyroid hormone (PTH) on lipid metabolism in chronic renal failure (CRF). Sixth International Capri Conference on Uremia. (Pathophysiology of patients treated for 15–20 years, Capri Island, Italy, September 1989 (p. 1).
Akmal, M., and Massry, S.G.: Reversible hepatic dysfunction. Nephrology in 1989, at Washington, DC.
Fadda, G.Z.; Akmal, M.; Lipson, L. and Massry, S.G.: Evidence for a direct effect of parathyroid hormone on pancreatic islets. Kid. Int. 37:466, 1990. Presented at the 22nd. Annual Meeting of the American Society of Nephrology in 1989, at Washington, DC.
Sawelson, S.; Akmal, M.; Gadallah, M; Karubian, F. and Massry, S.G.: Incidence and cause of gastrointestinal bleeding in uremic, hemodialysis (HD) and chronic ambulatory peritoneal dialysis patients. Kid. Int. 37:244, 1990.
Akmal, M.; Kasim, S.E.; Soliman, A.R. and Massry, S.G.: The adverse effects of excess-parathyroid hormone on lipid metabolism in chronic renal failure. International symposium on calcium regulating hormones, body fluids and kidney. Abstract 37, 1990, NARA, JAPAN. Presented in July 1990, at Nara, Japan.
Akmal, M.; Barndt, R.; Ansari, A. and Massry, S.G.: Right pulmonary artery pressure (MAP) and lung calcification in chronic renal failure (CRF). JACN, Page 583, 1990.
Kaptein, E.; Levenson, H. and Akmal, M.: Determination of radioiodine dose for papillary thyroid carcinoma (CA) in 68.p 90. Presented at the 23rd. Annual Meeting of the American Society of Nephrology, in 1990, at Washington, DC.
El-Shahawy, M.; Francis, R.; Akmal, M.; Massry, S.G.: Recombinant human erythropoietin shortens bleeding time (BT), and corrects abnormal platelet aggregation (PA) in hemodialysis patients (HDP). JACN 42 p.90. Presented at 23rd. Annual Meeting of the American Society of Nephrology, in 1990, at Washington DC.
Macko, R.; Ameriso, S.F.; Akmal, M.: Cerebral artery velocity. Neurology G40p, 91. Presented at the Academy of Neurology, 43rd Annual Meeting Program, April 1991, at Boston, MA.
Levenson, H.I; Akmal, M.; Siegel, M.E. and Kaptein, E.M.: Radioiodine dosage for papillary thyroid carcinoma in chronic ambulatory peritoneal dialysis (CAPD). Nuclear Medicine, 1991. Presented at the Annual Meeting of Nuclear Medicine in June 1991, at Cincinnati, OH.
Macko, R.; Aeriso, S.F.; Akmal, M.; Mohler, J.; Massry, S.G.; Meiselman, H.J.; Fisher, M.: Arterial oxygen content is a fundamental determinant of middle cerebral artery blood flow velocity. Presented at the 17th International Joint Conference on Stroke and Cerebral Circulation, Phoenix, AZ. 1992.
Kaptein, E.; Levenson, H.; Siegel, M.E.; Akmal, M.: End-stage renal disease patients (ESRD) receiving chronic ambulatory peritoneal dialysis (CAPD) require reduced radioiodide dosage for thyroid carcinoma. Accepted for presentation at ATA, Rochester, MN, September 1992.
Akmal, M; Perkins, S.; Massry, S.G.: Parathyroidectomy and treatment with verapamil prevents tissue calcification in CRF. Presented at ASN, 1992.
El-Shahawy, M.; Francis, R.; Akmal, M.; Massry, S.G.: Recombinant Human Erythropoietin (r-HuPo) shortens bleeding time and correctly the abnormal aggregation in hemodialysis patients. Presented at 2nd Clinical Nephrology Meeting, Chicago (April 22–25, 1993) Clinical Nephrology Meetings of NFK.
Katz, M.D.; Difiori, J.L.; Kaptein, E.M.; Akmal, M.; Harrell, D.S.; Hanks, S.E.: Prolonging potency with endovascular stents for venous stenoses in dialysis grafts. 79th. Scientific Assembly and Annual Meeting of the Radiological Society of North America, Chicago (Nov. 28–Dec. 3, 1993).
Kaptein, E.M.; Katz, M. D.; Hanks, S.E.; Akmal, M.: Endovascular stents for venous stenosis prolong the patency of hemodialysis patients. JASN, p. 358, 1993. Presented at the American Society of Nephrology, 26th Annual Meeting at Boston. (Nov. 14–17) 1993.
Akmal, M; Hanks, S.E.; Katz, M.D.; Kaptein, E.M.: Limb edema as a complication of venous catheterization and arteriovenous (AV) access creation for hemodialysis. JASN, p.330, 1993. Presented at the American Society of Nephrology, 26th Annual Meeting at Boston. (Nov.14–17), 1993.
Liou, H.H.; Shooh-Shan, C.; Shi-Ching, T.; Ching-Chun, C.; Shih-Chun, W.; Tung-Po, H.; Akmal, M.: Intravenous or oral calcitriol treatment in chronic hemodialysis patients with secondary hyperparathyroidism: Comparative study. JASN, p. 723, 1993, Boston. (Nov. 14–17) 1993.
Akmal, M.; Massry, S.G.: Right ventricular hypertrophy (RVH) and pressure (RVP), mean pulmonary artery pressure (MPAP), diffusion capacity of lungs (DLCO) and lung calcification in chronic renal failure (CRF). Presented at Third International Conference on New Actions of Parathyroid Hormone. At Kyoto, Japan, April 18–21, 1994.
Liou H.H.; Lin K.P.; Tarng D.C.; Huang T.P.; Akmal, M.: Effect of intravenous calcitriol on peripheral nerve conduction velocity in hemodialysis patients. Presented at Third International Conference on new actions of Parathyroid Hormone. At Kyoto, Japan, April 18–21, 1994.
Lieu, H.H.; Lin K.P.; Akmal, M.: Effects of excess parathyroid hormone and intravenous 125, (OH) 2D3 (IVC) therapy on peripheral nerve conduction velocity (NCV) in HD patients. JASN 5(3):884, 1994.
Alexiewcz, M.; Smogorzewski, M.; Klin, M.; Akmal, M.; Massry, S.G.: Effect of treatment of hemodialysis patients (HD) with nifedipine on metabolism and function of polymorphonuclear leucocytes (PMNL). JASN 5:323, 1994. Presented at 27th Annual Meeting of American Society of Nephrology at Orlando, Florida, in Oct 1994.
Akmal, M.; Tak T.; Kaptein E.M.: Left ventricular hypertrophy (LVH) in HD patients with normal serum cholesterol (CH) and triglycerides (TG). JASN 5:487, 1994.
Alexiewicz, J.M; Smogorzewski, M.; Klin, M.; Akmal, M.; Massry, S.G: Effect of treatment of hemodialysis (HD) patients with nifedipine on metabolism and function of B-cells. JASN 6(3)572, 1995.
Akmal, M.; Tak T.; Kaptein E.M.: Left ventricular hypertrophy (LVH) in HD patients with normal serum cholesterol (CH) and triglycerides (TG). ISN, 1995.
Akmal, M.; Kaptein E.M.: Successful use of erythrpoietin (EPO) and intravenous iron therapy in pregnant HD patients. Poster Presented at 5th Annual Spring Clinical Nephrology Meetings of the NKF, April 22–26, 1996, Anaheim, CA. AJKD 27:A1, 1996.
Akmal, M.; Koss M.; Rea, T.E.: Renal lesions in treated leprosy patients. Poster Presentation at 5th Annual Spring Clinical Nephrology Meetings of the NKF, April 22–26, 1996, Anaheim, CA. AJKD 27: A1, 1996.
Akmal, M.; Azizullah Ansari; Massry, S.G.: Calcification in end-stage renal failure (ESRD), and the effect of excess parathyroid hormone (PTH). Poster Presentation at 5th Annual Spring Clinical Nephrology Meetings of the NKF, April 22–26, 1996, Anaheim, CA. AJKD 27: A1, 1996.
Alexiewicz, J.M.; Smogorzewski, M.; Gill, S.; Akmal, M.; Massry, S.G.: The course of effect of nifedipine therapy and its discontinuation on [Ca2+]i and phagocytosis (PHAG) of PMNL from hemodialysis patients. Oral Presentation at 5th Annual Spring Clinical Nephrology Meetings of the NKF, April 22–26, 1996. Anaheim, CA. AJKD 27:A1, 1996.
Weisman, M.L; Tak, T.; Akmal, M.: CK-MB activity in end-stage renal disease. JASN 7(9):A0401, 1996.
Akmal, M; Yassa, N; Kaptein, E.M: Left ventricular hypertrophy and carotid artery lesions in HD patients. JASN 7(9): A0943, 1996.
Alexiewicz, J. M; Smogorzewski, M.; Gill, S.; Akmal, M.; Massry, S.G: Time course of the effect of nifedipine therapy and its discontinuation on [CA2]i and proliferation of B cells from HD patients. JASN 7(9): A0337, 1996.
Ziouzenkova O.; Asatryan, L.; Akmal, M.; Wratten M.L; Tetta, C.; Sevanian, A.: Novel hemodialysis procedure utilizing antioxidants decreases oxidative stress during EX-VIVO circulation of blood. Presented at the American Society of Nephrology, at Philadelphia, 1998. Kid. Int. S 330, 1998.
Ash, S.R.; Levy, H.; Akmal, M.; Mankus, R.A.; Sutton, J.M.; Emery, D.R.; Scanlon, J.C.; Blake, D.E.; Carr D.J.: Treatment of severe tricyclic antidepressant overdose with BioLogic-DT system. Presented at the American Society of Nephrology, Miami, FL, 1999 (Abstract # SA748)
Hemodialysis in diabetic patients. Presentation in April 2000 at Second International Conference on Uremic Research, Nara, Japan.
Chronic Kidney Disease: Presentation in December, 2004 at Khyber Medical College, Peshawar, Pakistan. Pathophysiology, new realities and strategies. International scientific symposia arranged by Pakistani Physicians of North America.
Patla, R; Akmal, M.: Cat-bite pasteurella pneumotropica peritonitis. Presented at ACP, San Diego, 2009
Akmal, M; Arutyounian N.; Kaptein E.: Successful use of erythropoietin (EPO) as intravenous iron therapy in pregnant hemodialysis (HD) patients and long-term effects on children. 44th Annual Convention, San Juan, Puerto Rico, 2011
Books
Shades of Life: Sublime Joy Is in Living—how a young man’s journey through kidney disease helped his family find meaning in their lives. Vasundhara Raghavan and Mohammad Akmal, M.D. iUniverse Self Publishing, ISBN: 9781450254991, 2010.
